MARKET

ACRS

ACRS

Aclaris
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.110
+0.070
+6.73%
After Hours: 1.080 -0.03 -2.70% 17:58 04/02 EDT
OPEN
1.050
PREV CLOSE
1.040
HIGH
1.140
LOW
1.000
VOLUME
203.44K
TURNOVER
--
52 WEEK HIGH
7.15
52 WEEK LOW
0.7000
MARKET CAP
46.10M
P/E (TTM)
-0.4042
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ACRS stock price target is 4.500 with a high estimate of 5.00 and a low estimate of 3.500.

EPS

ACRS News

More
  • Wayne biopharma firm borrows $11M to fund new business strategy
  • American City Business Journals · 1d ago
  • Aclaris Therapeutics Secures $11 Million Term Loan Facility
  • GlobeNewswire · 2d ago
  • Aclaris Therapeutics Secures $11M Term Loan Facility
  • Benzinga · 2d ago
  • Edited Transcript of ACRS earnings conference call or presentation 25-Feb-20 10:00pm GMT
  • Thomson Reuters StreetEvents · 03/17 07:46

Industry

Biotechnology & Medical Research
+3.33%
Pharmaceuticals & Medical Research
+2.80%

Hot Stocks

Symbol
Price
%Change

About ACRS

Aclaris Therapeutics, Inc. is a dermatologist-led, biopharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological indications. The Company is also focused on the discovery and development of kinase inhibitors to treat inflammatory and immunological disorders and cancer. The Company’s drug discovery platform KINect technology is a kinase-focused drug discovery engine utilizing computational chemistry to integrate proprietary compound collections and highly experienced biologists and medicinal chemists to identify and advance potential candidates into preclinical and clinical development.
More

Webull offers kinds of Aclaris Therapeutics Inc stock information, including NASDAQ:ACRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACRS stock news, and many more online research tools to help you make informed decisions.